Using AI Risk Estimates in Prostate Cancer Treatment Decisions - Urology Times
Daniel Spratt, MD, explains how he layers MMAI results onto NCCN risk groups and how he manages discordant results in both directions.
Urology Times 5
Covers: Healthcare
Benchmarking AI Risk Estimates in Prostate Cancer Against STAR-CAP | Urology Times
Daniel Spratt, MD, explains what the STAR-CAP cohort is, what an MMAI risk estimate represents, and why calibration benchmarking differs from ...
How Well Do AI Risk Estimates Match Real-World Prostate Cancer Outcomes?
Daniel Spratt, MD, reviews how closely MMAI-predicted 10-year distant metastasis and prostate cancer–specific mortality tracked observed STAR-CAP ...
AI and prostate cancer: Balancing hope and caution - Urology Times
The algorithm segmented slide images into patches, assessing architecture, epithelium, and tumor microenvironment to generate a 0 to 1 risk score.
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
An AI -based risk mapping tool was able to accurately predict seminal vesicle invasion (SVI) in patients with Grade group 2 or higher prostate ...